Navigation Content
University of Wisconsin Madison College of Engineering
You are here:
  1. Home > 
  2. News > 
  3. News archive > 
  4. 2011 > 
  5. Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid



Detecting endotoxin, a lipid-polysaccharide combination that is found in the outer membranes of many types of bacteria, is a standard way to establish the presence of bacterial contamination in a wide range of drugs, medical supplies and equipment. The current technology is based on a complex mixture of proteins isolated from the blood of a horseshoe crab, says Nicholas Abbott, John T. and Magdalen L. Sobota Professor and chair of chemical and biological engineering at UW-Madison.



Abbott initially thought that the changes in the liquid crystalline droplets would be due to the adsorption of the endotoxin to the surfaces of the droplets, but the concentration was too low to justify this explanation. So Abbott and his graduate students I-Hsin Lin and Dan Miller along with colleagues in the NSF-sponsored UW-Madison Materials Research Science and Engineering Center determined that "the transition was not driven by adsorption of endotoxin over the surface of the liquid crystalline droplet, but instead by localization of the endotoxin at defects in the liquid crystal droplets."

The localization of impurities to defects is "ubiquitous" in material science, Abbott says, "and it appears that a similar phenomenon is occurring here, which then triggers the transition in the liquid crystal droplet. This is a fundamentally different mechanism that gives rise to a level of sensitivity which is 10,000 to 100,000 higher than surface-driven transitions seen in past studies of liquid crystalline systems, and it suggests the basis for a very high level of sensitivity in detection."

Additionally, defect-driven ordering transitions in liquid crystalline systems have not been reported previously, and it is also highly surprising that it is so specific to the particular structure of endotoxin, says Abbott.

The defect-driven phenomenon that Abbott found could be more broadly applicable than endotoxin, but, he says: "Endotoxin in itself is pretty important. Endotoxin comes from the outer membrane of Gram-negative bacteria and is considered a key indication of bacterial infection."


The current FDA-approved test for endotoxin is based on the blood of horseshoe crabs, which have evolved to combat infection by clotting their blood in the presence of endotoxin. Horseshoe crabs are captured, bled and then returned to the water. The horseshoe crab test is the "gold standard assay" for endotoxin, Abbott says, "but our system so far seems a bit more sensitive and does not involve any biological components. The change in optical appearance of the droplets is quite striking, and it occurs within a minute."

The discovery could be the start of a long road to commercialization, but Abbott cautions, "We have found a fundamental phenomenon, but it's a long path to have a validated technology that can replace the horseshoe crab assay."


David Tenenbaum